124 related articles for article (PubMed ID: 32806281)
1. Graphene oxide as a potential drug carrier - Chemical carrier activation, drug attachment and its enzymatic controlled release.
Trusek A; Kijak E; Granicka L
Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111240. PubMed ID: 32806281
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide.
Lv Y; Tao L; Annie Bligh SW; Yang H; Pan Q; Zhu L
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():652-660. PubMed ID: 26652419
[TBL] [Abstract][Full Text] [Related]
4. Sodium alginate conjugated graphene oxide as a new carrier for drug delivery system.
Fan L; Ge H; Zou S; Xiao Y; Wen H; Li Y; Feng H; Nie M
Int J Biol Macromol; 2016 Dec; 93(Pt A):582-590. PubMed ID: 27616692
[TBL] [Abstract][Full Text] [Related]
5. Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy.
Huang C; Hu X; Hou Z; Ji J; Li Z; Luan Y
J Colloid Interface Sci; 2019 Jun; 545():172-183. PubMed ID: 30878783
[TBL] [Abstract][Full Text] [Related]
6. Drug Carriers Based on Graphene Oxide and Hydrogel: Opportunities and Challenges in Infection Control Tested by Amoxicillin Release.
Trusek A; Kijak E
Materials (Basel); 2021 Jun; 14(12):. PubMed ID: 34207735
[TBL] [Abstract][Full Text] [Related]
7. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy.
Huang C; Wu J; Jiang W; Liu R; Li Z; Luan Y
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():15-24. PubMed ID: 29752084
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy.
Guo Y; Xu H; Li Y; Wu F; Li Y; Bao Y; Yan X; Huang Z; Xu P
J Biomater Appl; 2017 Jul; 32(1):54-65. PubMed ID: 28554233
[TBL] [Abstract][Full Text] [Related]
10. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
11. Normalization of doxorubicin release from graphene oxide: New approach for optimization of effective parameters on drug loading.
Hashemi M; Yadegari A; Yazdanpanah G; Omidi M; Jabbehdari S; Haghiralsadat F; Yazdian F; Tayebi L
Biotechnol Appl Biochem; 2017 May; 64(3):433-442. PubMed ID: 26878983
[TBL] [Abstract][Full Text] [Related]
12. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
Zhou T; Zhou X; Xing D
Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
[TBL] [Abstract][Full Text] [Related]
14. PEGylated doxorubicin cloaked nano-graphene oxide for dual-responsive photochemical therapy.
Wang L; Yu D; Dai R; Fu D; Li W; Guo Z; Cui C; Xu J; Shen S; Ma K
Int J Pharm; 2019 Feb; 557():66-73. PubMed ID: 30580088
[TBL] [Abstract][Full Text] [Related]
15. Facile preparation of antibacterial chitosan/graphene oxide-Ag bio-nanocomposite hydrogel beads for controlled release of doxorubicin.
Rasoulzadehzali M; Namazi H
Int J Biol Macromol; 2018 Sep; 116():54-63. PubMed ID: 29705108
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds.
Ardeshirzadeh B; Anaraki NA; Irani M; Rad LR; Shamshiri S
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():384-90. PubMed ID: 25579938
[TBL] [Abstract][Full Text] [Related]
17. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
[TBL] [Abstract][Full Text] [Related]
18. Simple method for fabrication of metal-organic framework within a carboxymethylcellulose/graphene quantum dots matrix as a carrier for anticancer drug.
Pooresmaeil M; Namazi H; Salehi R
Int J Biol Macromol; 2020 Dec; 164():2301-2311. PubMed ID: 32805288
[TBL] [Abstract][Full Text] [Related]
19. Well-defined Graphene Oxide as a Potential Component in Lung Cancer Therapy.
Zuchowska A; Jastrzebska E; Mazurkiewicz-Pawlicka M; Malolepszy A; Stobinski L; Trzaskowski M; Brzozka Z
Curr Cancer Drug Targets; 2020; 20(1):47-58. PubMed ID: 31736445
[TBL] [Abstract][Full Text] [Related]
20. SERS-fluorescence monitored drug release of a redox-responsive nanocarrier based on graphene oxide in tumor cells.
Chen H; Wang Z; Zong S; Wu L; Chen P; Zhu D; Wang C; Xu S; Cui Y
ACS Appl Mater Interfaces; 2014 Oct; 6(20):17526-33. PubMed ID: 25272041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
